openPR Logo
Press release

Dual Specificity Protein Kinase TTK Market Report 2018-2026 Focuses On Top Companies Bayer AG, Boston Pharmaceuticals, Les Laboratoires Servier SAS, Nerviano Medical Sciences Srl

01-15-2019 12:44 PM CET | Health & Medicine

Press release from: Coherent Market Insights - Pharmaceutical Industry

Dual Specificity Protein Kinase TTK

Dual Specificity Protein Kinase TTK

Protein kinase are critical regulators of diverse cellular functions and are widely known for their high affinity towards targets in a variety of pathological conditions. The pharmacology of kinase inhibitors have tremendously developed over the past two decades, facilitating most of the inhibitors to be available orally.

TTK is a dual specificity kinase, which has the ability to phosphorylate both tyrosine as well as serine/threonine residues. This gene is associated with cell proliferation, and is essential for chromosome orientation at the centromere during mitosis and is required for centrosome duplication. It is found to be a critical mitotic checkpoint protein for accurate segregation of chromosomes during mitosis. They have high utility as a therapeutic target in various application areas such as breast cancer, metastatic breast cancer, solid tumor, colorectal cancer, prostate cancer, pancreatic ductal adenocarcinoma, and others.

Dual Specificity Protein Kinase TTK Market – Dynamics

Increasing prevalence of various types of cancers such as breast cancer, metastatic breast cancer, solid tumor, colorectal cancer, prostate cancer, pancreatic ductal adenocarcinoma, and others is expected to contribute to significant growth of the dual specificity protein kinase TTK market. For instance, according to the Cancer Research UK, it is projected that around 17 million new cases of cancer will be registered across the globe in 2018. Moreover, as per the U.S. National Library of Medicine and National Institutes of Health, pancreatic ductal adenocarcinoma is one of the most lethal cancers worldwide with the highest incidence rates found in North America and in Western Europe while lower rates in Asian Africa, with the incidence rates of 7.2 and 2.8 per 100,000 populations, respectively in 2017.

Download the PDF brochure:
https://www.coherentmarketinsights.com/insight/request-pdf/2373

Increasing number of pipeline molecules of dual specificity protein kinase TTK as a targeted therapy for various types of cancer is expected to propel growth of the dual specificity protein kinase TTK market. The pipeline dual specificity protein kinase TTK constitutes around 10-12 molecules, out of which around 7 molecules are developed by companies and others by the universities/institutes. For instance, in 2017, Bayer AG completed phase I trial studies for its pipeline molecule Empesertib (BAY 1161909) in solid tumors in the U.S. Furthermore, increasing investment by pharmaceutical companies has influenced growth of the market.

Dual Specificity Protein Kinase TTK Market – Regional Insights

On the basis of region, the global dual specificity protein kinase TTK market is segmented into North America, Europe, Latin America, Asia Pacific, Middle East, and Africa. North America held dominant position in the global dual specificity protein kinase TTK market in 2017. This is owing to increasing research and development activities in oncology segment in the region. Moreover, rising incidence of various types of cancers is expected to propel growth of the market in this region. For instance, according to American Cancer Society, in 2017, around 13% of all the cancers diagnosed in adults aged 20 and above are rare cancers with the incidence of around 6 cases per 100,000 people per year.

Moreover, Asia pacific is expected to witness significant growth in the dual specificity protein kinase TTK market over the forecast period, owing to increasing R&D activities for cancer-based targeted therapies and government initiatives for cancer awareness in the region. For instance, in Australia, a non-profit organization called Rare Cancers Australia (RCA) is committed to improve the lives of patients with rare and less common cancers by promoting the significance of early diagnosis and increasing treatment options for the Australian population.

Dual Specificity Protein Kinase TTK Market – Competitive Landscape

Major players operating in the dual specificity protein kinase TTK market include Bayer AG, Boston Pharmaceuticals, Les Laboratoires Servier SAS, Nerviano Medical Sciences Srl, Netherlands Translational Research Center BV, and Pfizer Inc. Key players are focused on adopting market strategies such as new product developments and clinical trial approvals, in order to retain dominant position in the market. For instance, in September 2015, Servier and Nerviano Medical Sciences started their first in human clinical trial of the drug S 81694 (NMS-P153). This drug is an inhibitor of the mitotic checkpoint kinase MPS1.

Get Discount On This Report:
https://www.coherentmarketinsights.com/insight/request-discount/2373

About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:
Mr.Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email:sales@coherentmarketinsights.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Dual Specificity Protein Kinase TTK Market Report 2018-2026 Focuses On Top Companies Bayer AG, Boston Pharmaceuticals, Les Laboratoires Servier SAS, Nerviano Medical Sciences Srl here

News-ID: 1499002 • Views: 200

More Releases from Coherent Market Insights - Pharmaceutical Industry

Radiopharmaceuticals in Nuclear Medicine Market Advancements to Watch Out For 20 …
Coherent Market Insights released a new market study on 2018-2026 Radiopharmaceuticals Market with 100+ market data Tables, Pie Chat, Graphs & Figures spread through Pages and easy to understand detailed analysis. At present, the market is developing its presence. The Research report presents a complete assessment of the Market and contains a future trend, current growth factors, attentive opinions, facts, and industry validated market data. Ask For Sample Copy of Research
Outsourced Drug Discovery Market: Latest Advancements & Market Outlook 2019 to 2 …
Outsourced drug discovery is a contract-based process, which is conducted by the contract research organizations (CRO) and contract manufacturing organization (CMO). Contract research organization provides support to pharmaceutical, biotechnology, and medical device industries for drug discovery and development. CRO facilitates the various services such as biopharmaceutical development, biologic assay development, preclinical research, clinical trials, and pharmacovigilance, for drug discovery and development. Ask For a Sample Copy of This Business Report @
Cannabis Testing Services Market: New Business Opportunities and Investment Rese …
Cannabis market is highly influenced by rigorous legalization efforts, which are aiming for approval of cannabis for medicinal or recreational purpose. Various governments and regulatory authorities are taking efforts to legalize cannabis, owing to its medicinal benefits. Moreover, commercialization of cannabis-based products under the legalized standards require successful cannabis testing, which further results in lucrative growth opportunity for market players. Ask For a Sample Copy of This Business Report @ https://www.coherentmarketinsights.com/insight/request-sample/2976 Market
Global Myelodysplastic Syndrome (MDS) Treatment Market Balenced To Reach Insigni …
Myelodysplastic syndrome (MDS) is a disorder, which affects the bone marrow and produces immature blood cells. Bone marrow failure leads to lowering the levels of healthy blood cells circulation in the bloodstream. According to Seattle Cancer Care Alliance, around 80%-85% of people with MDS have more cells in their bone marrow than healthy people. According to National Organization for Rare Disorders, MDS deteriorates into a form of cancer in around

All 5 Releases


More Releases for TTK

Ceramic Coated Cookware Market Comprehensive Analysis: Check Latest Strategic Mo …
"The report titled Global Ceramic Coated Cookware Market is one of the most comprehensive and important additions to QY Research’s archive of market research studies. It offers detailed research and analysis of key aspects of the global Ceramic Coated Cookware market. The market analysts authoring this report have provided in-depth information on leading growth drivers, restraints, challenges, trends, and opportunities to offer a complete analysis of the global Ceramic Coated
Electric Mop Market Surprising Growth| Haier, BISSELL, Fmart, TTK Prestige
The Global Electric Mop Market report encloses vital statistical data of sales and revenue based on leading segment such as type, regions, applications, technology, and elite players in the global Electric Mop industry. The report aims at historical (2013-2019) occurrences, talks about the present status of the industry and also provides valuable forecast information up to 2026. A comprehensive analysis of contemporary trends, demand spectrum, growth rate, and key region-wise
Structural Heart Devices Market Emerging Growth by Edwards Lifesciences Corporat …
Geriatric population is the key segment augmenting the growth of the market. U.S. has a large number of geriatric population and as per American Heart Association, approximately 80% of the population who die of cardiovascular diseases are 65 or older. Thus, the rising population of geriatric age group will augment the growth of the market in the forecast time frame. Structural heart devices market is expected to observe a considerable
Global Dual Specificity Protein Kinase TTK Market Forecast 2019-2026
Global Dual Specificity Protein Kinase TTK Market: Overview The Global Dual Specificity Protein Kinase TTK Market is one of the fastest growing markets nowadays. It has shown good growth in previous few years. The global Dual Specificity Protein Kinase TTK market is anticipated to show more growth in the future. Dual Specificity Protein Kinase TTK market report provides you depth knowledge about the Dual Specificity Protein Kinase TTK market studies findings
Size of the Dual Specificity Protein Kinase TTK Market from 2018 to 2025
MarketResearchReports.Biz adds “Global Dual Specificity Protein Kinase TTK Market Share, Size, Trends and Forecast Market Research Report” reports to its database. This report provides a strategic analysis of the Dual Specificity Protein Kinase TTK and the growth estimates for the forecasted period. This report studies the Dual Specificity Protein Kinase TTK market status and outlook of global and United States, from angles of players, regions, product types and end industries; this
Dual Specificity Protein Kinase TTK (Cancer/Testis Antigen 96 or Monopolar Spind …
“The Report Dual Specificity Protein Kinase TTK (Cancer/Testis Antigen 96 or Monopolar Spindle 1 Like 1 or Phosphotyrosine Picked Threonine Protein Kinase or TTK or EC 2.7.12.1) - Pipeline Review, H2 2017 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz” Dual Specificity Protein Kinase TTK (Cancer/Testis Antigen 96 or Monopolar Spindle 1 Like 1 or Phosphotyrosine Picked Threonine Protein Kinase or TTK